logo

For the Inventor, By the Inventor

Old Tappan, NJ, United States of America

George Rodger Allen, Jr

This inventor holds 8 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Rodger Allen, Jr. Retrieved from https://idiyas.com/inventor/george-rodger-allen-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal8 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-1985

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4515791 - Substituted phenyl-1,2,4-triazolo[2,3-b]pyridazin-3(2H)ones as (1985-05-07),
2. 4293554 - Method of treating asthma (1981-10-06),
3. 4230705 - 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating (1980-10-28),
4. 4117130 - Method for treating anxiety in mammals (1978-09-26),
5. 4112095 - 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents (1978-09-05),
6. 4092311 - Hypotensive alkyl-3-[6-(aryl)-3-pyridazinyl]-carbazates (1978-05-30),
7. 4062958 - Method of treating anxiety and compositions therefor (1977-12-13),
8. 3936464 - 1-Acyl-3-[2-(4-phenyl-1-piperidinyl)ethyl]indolines (1976-02-03),

Title: The Innovative Journey of George Rodger Allen, Jr.

Introduction

George Rodger Allen, Jr. is a notable inventor based in Old Tappan, New Jersey, recognized for his significant contributions to the field of pharmaceutical inventions. With a portfolio of 8 patents to his name, Allen has demonstrated a commitment to advancing medical treatments, particularly in respiratory health.

Latest Patents

Among his latest patents, Allen has developed substituted phenyl-1,2,4-triazolo[2,3-b]pyridazin-3(2H)ones and substituted phenyl-1,2,4-triazolo[4,3-b]pyridazin-3(2H)-ones, both showcasing his innovative approach as potential anti-asthma agents. Additionally, his patent titled "A method of treating asthma in a warm-blooded animal using the compound 6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3(2H)-one" highlights his dedication to finding effective treatments for asthma, a condition affecting millions of individuals.

Career Highlights

Throughout his career, George Rodger Allen, Jr. has been associated with the American Cyanamid Company, a prominent player in the pharmaceutical sector. His work at this company has enabled him to apply his inventive ideas in a practical context, driving advancements in medical therapies that address critical health issues.

Collaborations

In his professional journey, Allen has collaborated with talented colleagues such as John W. Hanifin, Jr. and Daniel B. Moran. These collaborations have enriched his innovative processes and facilitated the sharing of knowledge essential for developing groundbreaking treatments.

Conclusion

George Rodger Allen, Jr.'s contributions to pharmaceutical innovation are noteworthy. His dedication to developing anti-asthma treatments through his diverse patents underlines the importance of inventors in enhancing public health. With a strong background at the American Cyanamid Company and collaborative efforts with esteemed colleagues, Allen continues to exemplify the spirit of invention, pushing the boundaries of what's possible in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…